Illumine Investment Management, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2052970
POULSBO, WA
Position in NBIX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$1,585,746
+$316,827 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
#341
of 768 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Illumine Investment Management, LLC holds $6,309,169 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (25.1% of the industry book) .
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,585,746 | 0 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $1,268,919 | 9,632 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $1,369,510 | 9,656 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,366,739 | 9,736 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,241,691 | 9,879 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,066,294 | 9,641 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,297,023 | 9,502 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||